Parmax Pharma informs about revised standalone financial results

29 Mar 2017 Evaluate

Parmax Pharma has informed about Revised Standalone Financial Results for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

45.28 -0.70 (-1.52%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...